Correction to: Scientific Reports https://doi.org/10.1038/s41598-022-23550-w, published online 09 November 2022
The original version of this Article contained errors in the Methodology and Results sections.
In the Methodology section, under the subheading ‘Vaccine construction’,
“An adjuvant 50S ribosomal protein L3 (UniProtKB—P60438) (https://www.uniprot.org/) was used on N terminal of vaccine. EAAAK, CPGPG, and AAY are the types of linker used to construct vaccine sequence21.”
now reads:
“An adjuvant 50S ribosomal protein L3 (UniProtKB—P60438) (https://www.uniprot.org/) was used on N terminal of vaccine. EAAAK, GPGPG, and AAY are the types of linker used to construct vaccine sequence21.”
Under the subheading ‘Assemblage of multi-epitope vaccine candidate sequence’,
“To form a sequence of vaccine, B- and T-cell epitopes, adjuvants, CPGPG, AAY and EAAAK were arranged manually.”
now reads:
“To form a sequence of vaccine, B- and T-cell epitopes, adjuvants, GPGPG, AAY and EAAAK were arranged manually.”
In the Results section, under the subheading ‘Vaccine construction’,
“Furthermore, T-cells and linkage of B-cells was made possible with the help of CPGPG and AYY linker, as shown in Fig. S2.”
now reads:
“Furthermore, T-cells and linkage of B-cells was made possible with the help of GPGPG and AAY linker, as shown in Fig. S2.”
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zaib, S., Akram, F., Liaqat, S.T. et al. Author Correction: Bioinformatics approach for the construction of multiple epitope vaccine against omicron variant of SARS-CoV-2. Sci Rep 15, 20049 (2025). https://doi.org/10.1038/s41598-025-04451-0
Published:
DOI: https://doi.org/10.1038/s41598-025-04451-0
